{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:52:49Z","timestamp":1791211969191,"version":"4.1.0"},"reference-count":50,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1128\/cdli.10.6.990-994.2003","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T20:11:30Z","timestamp":1068235890000},"page":"990-994","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Application of Beryllium Lymphocyte Proliferation Testing"],"prefix":"10.1128","volume":"10","author":[{"given":"Barbara P.","family":"Barna","sequence":"first","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine"},{"name":"Clinical Pathology"},{"name":"Cell Biology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195-5038"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine"},{"name":"Clinical Pathology"},{"name":"Cell Biology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195-5038"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Yen-Lieberman","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine"},{"name":"Clinical Pathology"},{"name":"Cell Biology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195-5038"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed A.","family":"Dweik","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine"},{"name":"Clinical Pathology"},{"name":"Cell Biology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195-5038"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Thomassen","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine"},{"name":"Clinical Pathology"},{"name":"Cell Biology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195-5038"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1183\/09031936.02.02232001","volume":"20","year":"2002","unstructured":"Amicosante, M., F. Berretta, A. Franchi, P. Rogliani, C. Dotti, M. Losi, R. Dweik, and C. Saltini. 2002. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. Eur. Respir. J.20:1174-1178.","journal-title":"Eur. Respir. J."},{"key":"e_1_3_1_3_2","first-page":"A712","volume":"151","year":"1995","unstructured":"Barna, B. P., S. Burgess, B. Jacobs, T. N. Markham, M. J. Thomassen, and H. P. Wiedemann. 1995. Beryllium lung disease: association of biopsy findings with bronchoalveolar lavage lymphocyte content and immune response to beryllium. Am. J. Respir. Crit. Care Med.151:A712.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000233436","volume":"73","year":"1984","unstructured":"Barna, B. P., S. D. Deodhar, T. Chiang, S. Gautam, and M. Edinger. 1984. Experimental beryllium-induced lung disease. I. Differences in immunologic responses to beryllium compounds in strains 2 and 13 guinea pigs. Int. Arch. Allergy Appl. Immunol.73:42-48.","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clim.2002.5211","volume":"103","year":"2002","unstructured":"Barna, B. P., R. A. Dweik, C. F. Farver, D. Culver, B. Yen-Lieberman, and M. J. Thomassen. 2002. Nitric oxide attenuates beryllium-induced IFN\u03b3 responses in chronic beryllium disease: evidence for mechanisms independent of IL-18. Clin. Immunol.103:169-175.","journal-title":"Clin. Immunol."},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/geno.2000.6218","volume":"66","year":"2000","unstructured":"Cai, H., P. S. White, D. Torney, A. Deshpande, Z. Wang, B. Marrone, and J. P. Nolan. 2000. Flow cytometry-based minisequencing: a new platform for high-throughput single-nucleotide polymorphism scoring. Genomics66:135-143.","journal-title":"Genomics"},{"key":"e_1_3_1_7_2","first-page":"201","volume":"135","year":"1987","unstructured":"Cullen, M. R., J. R. Kominsky, M. D. Rossman, M. G. Cherniack, J. A. Rankin, J. R. Balmes, J. A. Kern, R. P. Daniele, L. Palmer, G. P. Naegel, K. McManus, and R. Cruz. 1987. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am. Rev. Respir. Dis.135:201-208.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.cpm.0000051418.18963.cb","volume":"10","year":"2003","unstructured":"Culver, D. A., and R. A. Dweik. 2003. Chronic beryllium disease. Clin. Pulm. Med.10:72-79.","journal-title":"Clin. Pulm. Med."},{"key":"e_1_3_1_9_2","first-page":"470","volume":"64","year":"1951","unstructured":"Curtis, G. H. 1951. Cutaneous hypersensitivity due to beryllium. Arch. Dermatol.64:470-482.","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3949\/ccjm.58.2.157","volume":"58","year":"1991","unstructured":"Deodhar, S. D., and B. P. Barna. 1991. Immune mechanisms in beryllium lung disease. Clev. Clin. J. Med.58:157-160.","journal-title":"Clev. Clin. J. Med."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1378\/chest.63.3.309","volume":"63","year":"1973","unstructured":"Deodhar, S. D., B. P. Barna, and H. S. Van Ordstrand. 1973. A study of the immunologic aspects of chronic berylliosis. Chest63:309-313.","journal-title":"Chest"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/10473220120220","volume":"16","year":"2001","unstructured":"Deubner, D. C., M. Goodman, and J. Iannuzzi. 2001. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. Appl. Occup. Environ. Hyg.16:521-526.","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0013-9351(82)90059-7","volume":"27","year":"1982","unstructured":"Eisenbud, M. 1982. Origins of the standards for control of beryllium disease (1947-1949). Environ. Res.27:79-88.","journal-title":"Environ. Res."},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00043764-198303000-00012","volume":"25","year":"1983","unstructured":"Eisenbud, M., and J. Lisson. 1983. Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update. J. Occup. Med.25:196-202.","journal-title":"J. Occup. Med."},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.7326\/0003-4819-97-2-213","volume":"97","year":"1982","unstructured":"Epstein, P. E., J. H. Dauber, M. D. Rossman, and R. P. Daniele. 1982. Bronchoalveolar lavage in patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann. Intern. Med.97:213-216.","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI0215846","volume":"110","year":"2002","unstructured":"Fontenot, A. P., S. J. Canavera, L. Gharavi, L. S. Newman, and B. L. Kotzin. 2002. Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease. J. Clin. Investig.110:1473-1482.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0046-8177(70)80003-X","volume":"1","year":"1970","unstructured":"Freiman, D. G., and H. L. Hardy. 1970. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U. S. beryllium case registry. Hum. Pathol.1:25-44.","journal-title":"Hum. Pathol."},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0300-483X(02)00439-0","volume":"183","year":"2003","unstructured":"Frome, E. L., L. S. Newman, D. L. Cragle, S. P. Colyer, and P. F. Wambach. 2003. Identification of an abnormal beryllium lymphocyte proliferation test. Toxicology183:39-56.","journal-title":"Toxicology"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s001090000105","volume":"78","year":"2000","unstructured":"Gaede, K. R., U. Mamat, M. Schlaak, and J. Muller-Quernheim. 2000. Analysis of differentially regulated mRNAs in peripheral blood monocytes of berylliosis patients after in vitro stimulation. J. Mol. Med.78:293-299.","journal-title":"J. Mol. Med."},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/1523-1747.ep12260036","volume":"55","year":"1970","unstructured":"Hanifin, J. M., W. L. Epstein, and M. J. Cline. 1970. In vitro studies of granulomatous hypersensitivity to beryllium. J. Investig. Dermatol.55:284-288.","journal-title":"J. Investig. Dermatol."},{"key":"e_1_3_1_21_2","first-page":"197","volume":"28","year":"1946","unstructured":"Hardy, H. L., and I. R. Tabershaw. 1946. Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J. Ind. Hyg. Toxicol.28:197-211.","journal-title":"J. Ind. Hyg. Toxicol."},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004200100237","volume":"74","year":"2001","unstructured":"Henneberger, P. K., D. Cumro, D. D. Deubner, M. S. Kent, M. McCawley, and K. Kreiss. 2001. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int. Arch. Occup. Environ. Health74:167-176.","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/104732201750169633","volume":"16","year":"2001","unstructured":"Kent, M. S., T. G. Robins, and A. K. Madl. 2001. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility. Appl. Occup. Environ. Hyg.16:539-558.","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/clin.1994.1061","volume":"71","year":"1994","unstructured":"Kreiss, K., F. Miller, L. S. Newman, A. Ojo-Amaize, M. Rossman, and C. Saltini. 1994. Chronic beryllium disease\u2014from the workplace to cellular immunology, molecular immunogenetics, and back. Clin. Immunol. Immunopathol.71:123-129.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","volume":"30","year":"1996","unstructured":"Kreiss, K., M. M. Mroz, L. S. Newman, J. Martyny, and B. Zhen. 1996. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms\/m3. Am. J. Ind. Med.30:16-25.","journal-title":"Am. J. Ind. Med."},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985","volume":"148","year":"1993","unstructured":"Kreiss, K., M. M. Mroz, B. Zhen, J. W. Martyny, and L. S. Newman. 1993. Epidemiology of beryllium sensitization and disease in nuclear workers. Am. Rev. Respir. Dis.148:985-991.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/oem.54.8.605","volume":"54","year":"1997","unstructured":"Kreiss, K., M. M. Mroz, B. Zhen, H. Wiedemann, and B. P. Barna. 1997. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup. Environ. Med.54:605-612.","journal-title":"Occup. Environ. Med."},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00043764-198907000-00011","volume":"31","year":"1989","unstructured":"Kreiss, K., L. S. Newman, M. M. Mroz, and P. A. Campbell. 1989. Screening blood test identifies subclinical beryllium disease. J. Occup. Med.31:603-608.","journal-title":"J. Occup. Med."},{"key":"e_1_3_1_29_2","first-page":"267","volume":"35","year":"1993","unstructured":"Kreiss, K., S. Wasserman, M. M. Mroz, and L. S. Newman. 1993. Beryllium disease screening in the ceramics industry. J. Occup. Med.35:267-274.","journal-title":"J. Occup. Med."},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1289\/ehp.02110703","volume":"110","year":"2002","unstructured":"Lioy, P. J., C. P. Weisel, J. R. Millette, S. Eisenreich, D. Vallero, J. Offenberg, B. Buckley, B. Turpin, M. Zhong, M. D. Cohen, C. Prophete, I. Yang, R. Stiles, G. Chee, W. Johnson, R. Porcja, S. Alimokhtari, R. C. Hale, C. Weschler, and L. C. Chen. 2002. Characterization of the dust\/smoke aerosol that settled east of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001. Environ. Health Perspect.110:703-714.","journal-title":"Environ. Health Perspect."},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1164\/ajrccm.164.7.2012123","volume":"164","year":"2001","unstructured":"Maier, L. A., R. T. Sawyer, R. A. Bauer, L. A. Kittle, P. A. Lympany, D. McGrath, R. Dubois, E. Daniloff, C. S. Rose, and L. S. Newman. 2001. High beryllium-stimulated TNF-\u03b1 is associated with the \u2212308 TNF-\u03b1 promoter polymorphism and with clinical severity in chronic beryllium disease. Am. J. Respir. Crit. Care Med.164:1192-1199.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00377860","volume":"68","year":"1996","unstructured":"Markham, T. N. 1996. Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing. Int. Arch. Occup. Environ. Health68:405-407.","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/aje\/kwg001","volume":"157","year":"2003","unstructured":"McCanlies, E. C., K. Kreiss, M. Andrew, and A. Weston. 2003. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am. J. Epidemiol.157:388-398.","journal-title":"Am. J. Epidemiol."},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1164\/ajrccm.150.1.8025739","volume":"150","year":"1994","unstructured":"Newman, L. S., C. Bobka, B. Schumacher, E. Daniloff, B. Zhen, M. M. Mroz, and T. E. King, Jr. 1994. Compartmentalized immune response reflects clinical severity of beryllium disease. Am. J. Respir. Crit. Care Med.150:135-142.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/ajrccm\/145.5.1212","volume":"145","year":"1992","unstructured":"Newman, L. S., and K. Kreiss. 1992. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium. Am. Rev. Respir. Dis.145:1212-1214.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","volume":"139","year":"1989","unstructured":"Newman, L. S., K. Kreiss, T. E. King, Jr., S. Seay, and P. A. Campbell. 1989. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am. Rev. Respir. Dis.139:1479-1486.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00043764-200103000-00011","volume":"43","year":"2001","unstructured":"Newman, L. S., M. M. Mroz, L. A. Maier, E. M. Daniloff, and R. Balkissoon. 2001. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J. Occup. Environ. Med.43:231-237.","journal-title":"J. Occup. Environ. Med."},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/10473220121280","volume":"16","year":"2001","unstructured":"Paustenbach, D. J., A. K. Madl, and J. F. Greene. 2001. Identifying an appropriate occupational exposure limit (OEL) for beryllium: data gaps and current research initiatives. Appl. Occup. Environ. Hyg.16:527-538.","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","volume":"32","year":"1997","unstructured":"Richeldi, L., K. Kreiss, M. M. Mroz, B. Zhen, P. Tartoni, and C. Saltini. 1997. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am. J. Ind. Med.32:337-340.","journal-title":"Am. J. Ind. Med."},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","volume":"262","year":"1993","unstructured":"Richeldi, L., R. Sorrentino, and C. Saltini. 1993. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science262:242-243.","journal-title":"Science"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","volume":"108","year":"1988","unstructured":"Rossman, M. D., J. A. Kern, J. A. Elias, M. R. Cullen, P. E. Epstein, O. P. Preuss, T. N. Markham, and R. P. Daniele. 1988. Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann. Intern. Med.108:687-693.","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","volume":"165","year":"2002","unstructured":"Rossman, M. D., J. Stubbs, C. W. Lee, E. Argyris, E. Magira, and D. Monos. 2002. Human leukocyte antigen class II amino acid epitopes. Susceptibility and progression markers for beryllium hypersensitivity. Am. J. Respir. Crit. Care Med.165:788-794.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_1_43_2","first-page":"1","volume":"18","year":"2001","unstructured":"Saltini, C., L. Richeldi, M. Losi, M. Amicosante, C. Voorter, E. van den Berg-Loonen, R. A. Dweik, H. P. Wiedemann, D. C. Deubner, and C. Tinelli. 2001. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur. Respir. J.18:1-8.","journal-title":"Eur. Respir. J."},{"key":"e_1_3_1_44_2","first-page":"242","volume":"320","year":"1989","unstructured":"Saltini, C., K. Winestock, M. Kirby, P. Pinkston, and R. G. Crystal. 1989. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N. Engl. J. Med.320:242-244.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.7.2.307-311.2000"},{"key":"e_1_3_1_46_2","first-page":"1011","volume":"117","year":"1978","unstructured":"Sprince, N. L., D. J. Kanarek, A. L. Weber, R. I. Chamberlin, and H. Kazemi. 1978. Reversible respiratory disease in beryllium workers. Am. Rev. Respir. Dis.117:1011-1017.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0002-9343(69)90074-6","volume":"46","year":"1969","unstructured":"Stoeckle, J. D., H. L. Hardy, and A. L. Weber. 1969. Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. Am. J. Med.46:545-561.","journal-title":"Am. J. Med."},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0300-483X(01)00410-3","volume":"165","year":"2001","unstructured":"Wang, Z., G. M. Farris, L. S. Newman, Y. Shou, L. A. Maier, H. N. Smith, and B. L. Marrone. 2001. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology165:27-38.","journal-title":"Toxicology"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ajim.10072","volume":"41","year":"2002","unstructured":"Weston, A., J. Ensey, K. Kreiss, C. Keshava, and E. McCanlies. 2002. Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for chronic beryllium disease. Am. J. Ind. Med.41:457-465.","journal-title":"Am. J. Ind. Med."},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/thx.38.1.41","volume":"38","year":"1983","unstructured":"Williams, W. J., and W. R. Williams. 1983. Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers. Thorax38:41-44.","journal-title":"Thorax"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000233010","volume":"67","year":"1982","unstructured":"Williams, W. R., and W. J. Williams. 1982. Development of beryllium lymphocyte transformation in chronic beryllium disease. Int. Arch. Allergy Appl. Immunol.67:175-180.","journal-title":"Int. Arch. Allergy Appl. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.10.6.990-994.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.10.6.990-994.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:33:44Z","timestamp":1627590824000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.10.6.990-994.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1128\/CDLI.10.6.990-994.2003"],"URL":"https:\/\/doi.org\/10.1128\/cdli.10.6.990-994.2003","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}